Market Trends of Global Uterine Manipulation Devices Industry
This section covers the major market trends shaping the Uterine Manipulation Devices Market according to our research experts:
Total Laparoscopic Hysterectomy Segment is Expected to Account for the Largest Market Share During the Forecast Period
Total Laparoscopic Hysterectomy (TLH) is the removal of the uterus and cervix through four small (1/2'- 1') abdominal incisions. This procedure may also include the removal of the ovaries and tubes, depending on the patient. TLH is performed to treat diseases of the uterus, such as fibroids, pelvic pain infection in ovaries and vaginal tubes, abnormal vaginal bleeding, and others.
The factors such as the growing burden of these diseases and growing research and development studies are expected to boost the market growth. For instance, according to the research study published in August 2021, titled 'Uterine Fibroids: Assessing Unmet Needs from Bench to Bedside', smooth muscle tumors called leiomyomas, sometimes known as uterine fibroids, develop from the myometrium and using ultrasound detection, around 30%-35% of women will be identified as having fibroids, but it is predicted that more than 70% of women will do so by age 50 in the United States. Also, as per the same source, in the US, 25% of women with uterine fibroids will have symptoms bad enough to need medical attention. Hence, the high prevalence of fibroids among women is expected to increase the hysteroscopy procedures and uterine manipulators, as that is used in these procedures, thus driving the market.
Additionally, rising research studies proving the efficacy and safety of using uterine manipulators during TLH procedures will increase its adaptability, which will also contribute to market growth. For instance, according to the study 'Total Laparoscopic Hysterectomy with a Newly Designed Uterine Manipulator (Halder's): Safety, Efficacy and Perforation Prevention' published in April 2020, the Halder's uterine manipulator is an easy, smart and simple option to do TLH, which reduces the complications and have more favorable operative outcomes. This manipulator can be used by inexperienced persons at the vaginal end, thus, positively impacting the market growth. The study 'Laparoendoscopic Single Site Hysterectomy: Literature Review and Procedure Description,' published in April 2021, suggests that intra-uterine manipulator permits a better exposure of the pelvic field, helping the surgeon by exposing the correct surgical planes of the operative field. Thus, added advantages of uterine manipulators during TLH procedures will fuel the market growth. Thus, owing to the above-mentioned factors, the studied market is expected to grow significantly during the study period.
North America is Expected to Hold a Significant Share in the Market Over the Forecast Period
The primary driving factors for the growth of the North American uterine manipulator market are the rising burden of female reproductive system diseases such as cervical cancer, endometriosis, and others, rising demand for minimally invasive surgeries, and rising technological advancements.
The United States within North America contributes to significant growth in the studied market. The rising burden of these diseases in the country will boost the market. For instance, according to a January 2022 update by the American Cancer Society, approximately 14,100 new cases of invasive cervical cancer will be diagnosed in 2022 in the country, with estimated 4,280 women deaths from the disease. Thus, the high prevalence and mortality rate associated with cervical cancer will boost its early treatment, thereby driving the demand for uterine manipulator devices as they are used for addressing cervical cancer, thus boosting the market.
The rising research and development studies in the market will also boost the market growth. For instance, a prospective, multicenter, randomized non-inferiority phase III study was initiated in May 2021 to evaluate if patients undergoing a minimally invasive surgery for early-stage uterine cancer have cancer cells in the fluid that is obtained at the time of their surgery when a uterine manipulator is placed versus patients who do not have a uterine manipulator placed. Such studies will help in evaluating the efficacy and safety of uterine manipulators, which can boost their adaptability; therefore, such studies might contribute to market growth.
The article 'For Early-Stage Cervical Cancer, Minimally Invasive Surgery Declining,' published by National Cancer Institute in May 2021, suggested that uterine manipulators are used during minimally invasive procedures to improve the surgeon's ability to access and visualize the uterus and surrounding structures. Thus, as uterine manipulators assist surgeons during minimally invasive surgeries, the demand for the same is expected to grow during the study period, which will propel the market growth. Hence, owing to the above-mentioned factors, the studied market is expected to grow during the forecast period.
